Dxcover

Dxcover

Private
GlasgowHealthcare & Life Scienceshttps://dxcover.com

Last Round

VC Round

Feb 5, 2024

Total Funding Raised

$18.8M

Momentum Score

25 /100

Company Overview

Dxcover is a diagnostic equipment company that provides a liquid biopsy platform using infrared spectroscopy and artificial intelligence for the early detection of multiple cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

liquid biopsyearly cancer detectioncancer blood testAI diagnosticsbrain cancer testinfrared spectroscopymulti-omic spectral analysisMOSA-Dxsolid tumor detectionmedical diagnosticspatient triagebiopharma partneringLaboratory Developed TestLDTCE Marking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dxcover Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dxcover Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 5, 2024
GrantFeb 1, 2023
Series AFeb 1, 2023
SeedMar 4, 2021
SeedMar 28, 2019

Key People

Founding team and executive leadership

Matthew J. Baker

President Chief Executive Officer, Chief Executive Officer

Executive Team

Dxcover Investors

Notable investors and investment history

InvestorRounds
European Innovation CouncilGrant
University of StrathclydeVC Round, Series A, Seed
Eos AdvisorySeed, VC Round, Series A
Scottish Investment Bank (Scottish Enterprise)Seed, Series A
Macmillan Cancer SupportVC Round
Mercia VenturesSeed, Series A
SIS VenturesVC Round, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2025

    Added ESMO, a medical society, as a customer.

  • Nov 26, 2025

    Added Life Sciences Awards, a media/events startup, as a customer.

Dxcover Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dxcover Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dxcover's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range31
Year Founded2016
Last FundingFeb 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.